Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23169517 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
Conditions: Solid Tumors;   Cancer
Interventions: Drug: XL184;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.